Yes: They are studying a vaccine for glioblastoma. Results are pending but preliminary results are encouraging. Bevacizumab has been in use for about 3-4 years with impressive results. There are some phase 1 trials currently accruing at the nci. Hopefully this helped.
Answered 7/6/2020
5.7k views
8 doctors weighed in across 3 answers
4 doctors weighed in across 2 answers
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question